2-thioxanthine derivatives acting as MPO-inhibitors

Details for Australian Patent Application No. 2007256005 (hide)

Owner AstraZeneca AB

Inventors Tiden, Anna-Karin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007256005

PCT Pub. Number WO2007/142576

Priority 60/810,919 05.06.06 US

Filing date 4 June 2007

Wipo publication date 13 December 2007

Acceptance publication date 17 March 2011

International Classifications

C07D 473/22 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/522 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/142576 Priority application(s): WO2007/142576

17 March 2011 Application Accepted

  Published as AU-B-2007256005

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007256012-Muscarinic receptor agonists that are effective in the treatment of pain, Alzheimer's disease and schizophrenia.

2007255999-Arrangement for venting of hydraulic system in motor vehicle